Yeast Fermentation for VLP Production

• Unpacking the Science of Yeast Fermentation for Optimal VLP Production

  While can make VLPs, yeast fermentationcan also help produce the other critical proteins and enzymes we need in our bodies. To name just one, insulin - an essential treatment for those afflicted with diabetes - is now produced through yeast fermentation. If anything, it is just a demonstration of what yeast can be used for in such wide ranging projects and the potential uses it has to offer many industries.

• A Key Component in Next-Gen VLP Manufacturing

  One of the hardest parts about making VLPs, Clover said, is ensuring that they remain both high-quality and produced at exactly the same amounts each time. This requires each batch of VLPs to be consistent so they are efficacious in vaccines. Indeed, yeast fermentation technology has come a long way in the last several years. Modifications of the process by scientists to boost production VLPs are many. Special facilities that have the right growing conditions for yeast to flourish and produce large quantities of VLPs are erected.

• Putting Yeast Fermentation to Work for Reliable VLP Production at Scale

  VLPs are continually being produced by yeast fermentation with further refinements in the pipeline as scientists work to improve on perfection. They study optimal yeast conditions, test various types of yeasts, and then tweak the genes that code for viral proteins. With these advancements, VLPs will be produced in a more efficient and cost-effective manner. This allows more people around the world to benefit from these vaccines and treatments.

Why choose Yaohai Yeast Fermentation for VLP Production?

• Robust Supply Chain & Manufacturing Capabilities

  Yaohai Bio-Pharma, a top 10 producer of biological products, is a specialist in microbial fermentation. We have established an advanced facility that is equipped with modern facilities and strong RD manufacturing capabilities. We have five drug substance manufacturing lines that are in compliance with GMP requirements for microbial fermentation and purification, as well as two fill-finish lines that are automated for cartridges, vials, as well as pre-filled syringes. The available fermentation scales vary from 100L to 500L, 1000L and 2000L. Yeast Fermentation for VLP Production for vias are 1ml to 25ml, whereas the pre-filled syringes and cartridge filling specifications cover 1-3ml. Our production workshop is cGMP compliant and guarantees steady supply of clinical samples as well as commercial items. Our plant produces large molecules which are shipped to the globe.

• Professional Expertise & Extensive Experience

  Yaohai Bio-Pharma is a leading in microbial biologics CDMO. Our main focus has been the production of microbial vaccinations and therapeutics to manage the health of pets, humans and animals. health. We have modern RD and manufacturing technology platforms that cover the entire process, from microbial strain engineering, cell banking, process and method design to commercial and clinical manufacturing, which ensures the success supply of the most cutting-edge solutions. Through the years we have gained vast expertise in using microbial sources. Over 200 projects were successfully completed. In addition, we support our clients in get through regulations, such as those of the US FDA as well as EU EMA. We also help them to navigate Australia TGA and China NMPA. Our expert knowledge and vast experience allow us to quickly respond to market demands and provide Yeast Fermentation for VLP Production CDMO services.

• Quality System & Global Regulatory Compliance

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality control and Yeast Fermentation for VLP Production. We have developed a solid quality system that adheres to current GMP standards and regulatory requirements worldwide. Our regulatory team is knowledgeable on global regulatory frameworks to expedite biological launches. We make sure that production processes are traceable with high-quality products as well as complying with the rules of the US FDA and EU EMA. Australia TGA and China NMPA are also in compliance. Yaohai BioPharma successfully passed an on-site audit conducted by a Qualified Person from the European Union (QP) to examine our GMP process and manufacturing facility. We also successfully been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Customization, Efficiency & Cost-Effectiveness

  Yaohai Bio-Pharma has experience in the manufacture of biologics derived from microorganisms. We offer tailored RD solutions and manufacturing while minimizing the risk. We have worked with diverse methods, such as Yeast Fermentation for VLP Production of vaccines (including peptides), growth factors, hormones, and Cytokines. We specialized in multiple microbial hosts, including yeast extracellular and intracellular (yield up to 15 g/L) bacteria periplasmic secretion, soluble intracellular, and inclusion bodies (yield up to 10 grams/L). We also have a BSL-2 fermentation platform to create bacterial vaccines. We specialize in improving processes, increasing product yields, as well as reducing production costs. We have an efficient technology team that guarantees timely and quality project delivery. This allows us to deliver your exclusive products quicker to market.

Related product categories

Not finding what you're looking for?
Contact our consultants for more available products.